Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a newer version of the ClinicalTrials.gov record. This represents an administrative update rather than a change to study details or outcomes.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s displayed revision marker was updated from version v3.5.2 to v3.5.3, reflecting a release of the site interface rather than any change to the trial record itself.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3 from the history.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous v3.4.2 in the page footer.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.